Adoptive Cell Transfer Incorporating Vaccination (ACTIV) Therapy for Cancer [ 2016 - 2018 ]

Research Grant

Researchers: A/Pr Michael Kershaw (Principal investigator) ,  A/Pr Phillip Darcy ,  Dr Clare Slaney

Brief description We have made a breakthrough in a new treatment for cancer that can destroy large tumours in mice. The treatment involves a transfusion of white blood cells and an injection of a vaccine. In this project, we will seek to understand how the treatment works, and apply it to human white blood cells in preparation for a clinical trial in cancer patients.

Funding Amount $AUD 618,962.46

Funding Scheme Project Grants

Notes Standard Project Grant